What are the causes of low testosterone in a 39-year-old female taking escitalopram (Lexapro), vaginal ring, and recently completed a 10-day course of methylprednisolone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Low testosterone (T) levels in a 39-year-old female could be related to several factors, including her current medications, such as escitalopram and the vaginal ring, as well as the recent course of methylprednisolone, which may still be affecting the hypothalamic-pituitary-adrenal axis 1.

Potential Causes of Low Testosterone

  • Escitalopram, an SSRI antidepressant, can affect hormone levels and potentially decrease testosterone production
  • The vaginal ring, likely containing hormonal contraceptives, impacts the endocrine system and may suppress testosterone
  • The recent course of methylprednisolone could still be affecting the hypothalamic-pituitary-adrenal axis, which plays a role in testosterone regulation
  • Age-related hormonal changes, stress, poor sleep, and underlying medical conditions like thyroid disorders or polycystic ovary syndrome could contribute to low testosterone

Recommendation

I recommend consulting with an endocrinologist for proper evaluation, including comprehensive hormone testing, as suggested by the Endocrine Society Clinical Practice Guideline 2. Treatment options might include adjusting current medications if possible, hormone replacement therapy if indicated, lifestyle modifications like regular exercise and stress management, and addressing any underlying medical conditions. Understanding the normal testosterone range for females (typically 15-70 ng/dL) is important, as symptoms like fatigue, decreased libido, and mood changes can occur with low levels.

Importance of Recent and High-Quality Evidence

The most recent and highest quality study, such as the one published in 2018 by the Endocrine Society 2, provides guidance on the diagnosis and treatment of hypogonadism, which is essential in addressing low testosterone levels in females.

Considerations for Treatment

When considering treatment options, it is essential to weigh the potential benefits and risks, as well as involve the patient in decision-making, as recommended by the Endocrine Society Clinical Practice Guideline 2. Additionally, monitoring testosterone therapy is crucial to ensure that testosterone concentrations are within the mid-normal range during treatment, taking into consideration patient preference, pharmacokinetics, formulation-specific adverse effects, treatment burden, and cost 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.